constipation
Conditions
Interventions
1-kestose (3g/day,2months)
Maltose (3g/day,2months)
Sponsors
Center for Preventive Medical Sciences, Chiba University
Chiba University Hospital Nouvelle Place Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those who have consented to participate in the trial from their substitute (guardian) 2) Those who defecate less than 4 times a week 3) Those whose age at the time of obtaining consent by their parents is 3 to 6 years old 4) Those who are certified as No. 1 childcare certification
Exclusion criteria
Exclusion criteria: 1) Those who have a chronic illness and plan to start, end or change drug treatment during the trial period, or those who have a history of serious illness 2) Those who are allergic to test foods 3) Those who plan to start or end the intake of probiotics / prebiotics preparations or foods during the trial period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the number of defecation days per week (according to the questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| Average number of defecation per week (according to a questionnaire) Fecal properties (by Bristol stool property scale / questionnaire) Changes in the intestinal flora in feces Changes in the number of copies of intestinal bacteria in feces Changes in short-chain fatty acids in feces Incidence of adverse events | — |
Countries
Japan
Contacts
Public ContactMayuko Takahashi
B food science Co., Ltd. Research unit, Research & Development center
Outcome results
None listed